IMPROVING THE ENTANGLEMENT DIVERSION BETWEEN TWO PAIRS OF ENTANGLED COHERENT STATES
- 期刊名称International Journal of Modern Physics B
- 作者PRAKASH, H.; CHANDRA, N.; PRAKASH, R.; KUMAR, SHIVANI A.
- 卷第24卷
- 期第17期
- 印刷ISSN0217-9792
- 电子ISSN1793-6578
- 文件大小173.50KB
- 发表时间2010-07-10
- DOI10.1142/S0217979210053331
- 页码3331-3339
Long Residence Time Inhibition of EZH2 in Activated Polycomb Repressive Complex 2Van Aller, Glenn S.; Pappalardi, Melissa Baker; Ott, Heidi M.; Diaz, Elsie; Brandt, Martin; Schwartz, Benjamin J.; Miller, William H.; Dhanak, Dashyant; McCabe, Michael T.; Verma, Sharad K.; Creasy, Caretha L.; Tummino, Peter J.; Kruger, Ryan G. · ACS Chemical Biology · 2014
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressorsZingg, Daniel; Debbache, Julien; Schaefer, Simon M.; Tuncer, Eylul; Frommel, Sandra C.; Cheng, Phil; Arenas-Ramirez, Natalia; Haeusel, Jessica; Zhang, Yudong; Bonalli, Mario; McCabe, Michael T.; Creasy, Caretha L.; Levesque, Mitchell P.; Boyman, Onur; Santoro, Raffaella; Shakhova, Olga; Dummer, Reinhard; Sommer, Lukas · Nature Communications · 2015
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2Verma, Sharad K.; Tian, Xinrong; LaFrance, Louis V.; Duquenne, Céline; Suarez, Dominic P.; Newlander, Kenneth A.; Romeril, Stuart P.; Burgess, Joelle L.; Grant, Seth W.; Brackley, James A.; Graves, Alan P.; Scherzer, Daryl A.; Shu, Art; Thompson, Christine; Ott, Heidi M.; Aller, Glenn S. Van; Machutta, Carl A.; Diaz, Elsie; Jiang, Yong; Johnson, Neil W.; Knight, Steven D.; Kruger, Ryan G.; McCabe, Michael T.; Dhanak, Dashyant; Tummino, Peter J.; Creasy, Caretha L.; Miller, William H. · ACS Medicinal Chemistry Letters · 2012
EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid TransformationBéguelin, Wendy; Popovic, Relja; Teater, Matt; Jiang, Yanwen; Bunting, Karen L.; Rosen, Monica; Shen, Hao; Yang, Shao Ning; Wang, Ling; Ezponda, Teresa; Martinez-Garcia, Eva; Zhang, Haikuo; Zheng, Yupeng; Verma, Sharad K.; McCabe, Michael T.; Ott, Heidi M.; Van Aller, Glenn S.; Kruger, Ryan G.; Liu, Yan; McHugh, Charles F.; Scott, David W.; Chung, Young Rock; Kelleher, Neil; Shaknovich, Rita; Creasy, Caretha L.; Gascoyne, Randy D.; Wong, Kwok-Kin; Cerchietti, Leandro; Levine, Ross L.; Abdel-Wahab, Omar; Licht, Jonathan D.; Elemento, Olivier; Melnick, Ari M. · Cancer Cell · 2013
Phase 1 study of the novel enhancer of zeste homolog 2 (EZH2) inhibitor GSK2816126 in patients with advanced hematological and solid tumorsYap, Timothy A.; Winter, Jane N; Giulino-Roth, Lisa; Longley, Jemma; Lopez, Juanita S; Michot, Jean-Marie; Leonard, John P.; Ribrag, Vincent; McCabe, Michael T.; Creasy, Caretha L.; Stern, Melissa; Pene Dumitrescu, Teodora; Wang, Xiaowei; Frey, Steve; Carver, Jennifer; Horner, Thierry; Oh, Choon; Khaled, Ahmed; Dhar, Arindam X; Johnson, Peter WM · Clinical Cancer Research · 2019
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP LossFedoriw, Andrew; Rajapurkar, Satyajit R.; O'Brien, Shane; Gerhart, Sarah V.; Mitchell, Lorna H.; Adams, Nicholas D.; Rioux, Nathalie; Lingaraj, Trupti; Ribich, Scott A.; Pappalardi, Melissa B.; Shah, Niyant; Laraio, Jenny; Liu, Yan; Butticello, Michael; Carpenter, Chris L.; Creasy, Caretha; Korenchuk, Susan; McCabe, Michael T.; McHugh, Charles F.; Nagarajan, Raman; Wagner, Craig; Zappacosta, Francesca; Annan, Roland; Concha, Nestor O.; Thomas, Roberta A.; Hart, Timothy K.; Smith, Jesse J.; Copeland, Robert A.; Moyer, Mikel P.; Campbell, John; Stickland, Kim; Mills, James; Jacques-O’Hagan, Suzanne; Allain, Christina; Johnston, Danielle; Raimondi, Alejandra; Porter Scott, Margaret; Waters, Nigel; Swinger, Kerren; Boriack-Sjodin, Ann; Riera, Tom; Shapiro, Gideon; Chesworth, Richard; Prinjha, Rabinder K.; Kruger, Ryan G.; Barbash, Olena; Mohammad, Helai P. · Cancer Cell · 2019
Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2Ler, Lian Dee; Ghosh, Sujoy; Chai, Xiaoran; Thike, Aye Aye; Heng, Hong Lee; Siew, Ee Yan; Dey, Sucharita; Koh, Liang Kai; Lim, Jing Quan; Lim, Weng Khong; Myint, Swe Swe; Loh, Jia Liang; Ong, Pauline; Sam, Xin Xiu; Huang, Dachuan; Lim, Tony; Tan, Puay Hoon; Nagarajan, Sanjanaa; Cheng, Christopher Wai Sam; Ho, Henry; Ng, Lay Guat; Yuen, John; Lin, Po-Hung; Chuang, Cheng-Keng; Chang, Ying-Hsu; Weng, Wen-Hui; Rozen, Steven G.; Tan, Patrick; Creasy, Caretha L.; Pang, See-Tong; McCabe, Michael T.; Poon, Song Ling; Teh, Bin Tean · Science Translational Medicine · 2017
miRNAs as mediators of drug resistanceHaenisch, Sierk; Cascorbi, Ingolf · Epigenomics · 2012
DNA demethylation by TDGDalton, Shannon R; Bellacosa, Alfonso · Epigenomics · 2012
Epigenetics of autoimmune diabetesJayaraman, Sundararajan · Epigenomics · 2011
CG methylationVinson, Charles; Chatterjee, Raghunath · Epigenomics · 2012
REST: transcriptional and epigenetic regulatorBithell, Angela · Epigenomics · 2011
Bisulfite methylation profiling of large genomesReinders, Jon; Paszkowski, Jerzy · Epigenomics · 2010
DNA methylation and field cancerizationRamachandran, Kavitha; Singal, Rakesh · Epigenomics · 2012
Epigenetics and lifestyleAlegría-Torres, Jorge Alejandro; Baccarelli, Andrea; Bollati, Valentina · Epigenomics · 2011